RT @BogochIsaac: No benefit of hydroxychloroquine in a well-designed study: "Among patients hospitalized with mild-to-moderate #COVID19, t…
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
RT @DrDenaGrayson: 🚨BREAKING: Randomized study shows that #hydroxychloroquine ± azithromycin has NO BENEFIT in patients with mild/moderate…
RT @EricTopol: Another day, another report on hydoxychloroquine absence of efficacy. New @NEJM trial published today https://t.co/k2oCZhtw0…
RT @Capyvara: Estudo nacional randomizado testando Hidroxicloroquina e Azitromicina. feito com a coalisão dos principais hospitais e instit…
What's the Portuguese word for zinc 🤪 #COVIDIOTS
Olha outra surpresa do nível da do Cavani. https://t.co/Gkq6L7snwZ
Another important example of doing a rigorous randomized trial Thx to the people in Brazil @RenatoDLopes1 Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 | NEJM https://t.co/iQW7yX16Q1
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
Une RCT de plus qui discrédite Raoult HCQ+AZT ! Manque rien "Mild to moderate Covid" ! Donc on peut pas dire que ce sont des cas tp graves. Et l'étude vient du Brésil, un pays où Bolso ferait n'importe quoi pour vendre l'HCQ à ses détracteurs ! Même si ça
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
RT @Capyvara: Estudo nacional randomizado testando Hidroxicloroquina e Azitromicina. feito com a coalisão dos principais hospitais e instit…
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
RT @Capyvara: Estudo nacional randomizado testando Hidroxicloroquina e Azitromicina. feito com a coalisão dos principais hospitais e instit…
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
Teknik bir soru: Türkiye’de #HCQ içeren tedavi protokollerinin #EtikKurul onayı öncesinde hastalar sigortalandılar mı? #COVID19 #BilimKurulu #bilimselaraştırma #EtikKurul #NEJM Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 h
RT @PauloLotufo: Alô ! Imprensa brasileira. Médica de primeira linha e pesquisadora qualificada. Incrível, conheço vários dos autores, alg…
Brazilian 🇧🇷 multicenter RCT looking at HCQ just published in NEJM.
RT @PauloLotufo: Brasil chuta a cloroquina. Parabéns, aos meus seguidores @f_g_zampieri @leticiakawano pela publicação e pelo sigilo mantid…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @Larhumato: .@raoult_didier a beau clamer haut et fort que « son » hydroxychloroquine et « son » azithromycine sont efficaces, inlassabl…
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
RT @lavieri: Infelizmente, não vai mudar nada para os cloroquiners. Vão dizer que não adianta para hospitalizados, mas apenas para quem est…
RT @DrDenaGrayson: 🚨BREAKING: Randomized study shows that #hydroxychloroquine ± azithromycin has NO BENEFIT in patients with mild/moderate…
RT @CMichaelGibson: Among patients hospitalized with mild-to-moderate #Covid19, the use of hydroxychloroquine, alone or with azithromycin,…
Nouvelle étude NEJM sur HCQ : Ça progresse, et toujours vers + de "bah non ça marche pas". Il serait peut-être temps de passer à autre chose plutôt que de cramer les budgets de la recherche et le temps des chercheurs dans cette voie inutile.
Estudo nacional randomizado testando Hidroxicloroquina e Azitromicina. feito com a coalisão dos principais hospitais e institutos de pesquisa. Não foi demonstrado efeito benéfico algum e mais eventos adversos em doentes hospitalizados.
RT @Larhumato: .@raoult_didier a beau clamer haut et fort que « son » hydroxychloroquine et « son » azithromycine sont efficaces, inlassabl…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @BogochIsaac: No benefit of hydroxychloroquine in a well-designed study: "Among patients hospitalized with mild-to-moderate #COVID19, t…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals. https://t.co/v2CunAcerA
Alô ! Imprensa brasileira. Médica de primeira linha e pesquisadora qualificada. Incrível, conheço vários dos autores, alguns foram meus alunos ou residentes Devem ter assistido a alguma aula de epidemiologia clínica, depois viraram "feras em ensaios clín
RT @BogochIsaac: No benefit of hydroxychloroquine in a well-designed study: "Among patients hospitalized with mild-to-moderate #COVID19, t…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals. https://t.co/v2CunAcerA
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
RT @jdflaysakier: L’essai brésilien HCQ+ azithro mentionné plus tôt cet après-midi. Randomisé, formes legères et modérées de #Covid_19 ESS…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals. https://t.co/v2CunAcerA
RT @BogochIsaac: No benefit of hydroxychloroquine in a well-designed study: "Among patients hospitalized with mild-to-moderate #COVID19, t…
RT @BogochIsaac: No benefit of hydroxychloroquine in a well-designed study: "Among patients hospitalized with mild-to-moderate #COVID19, t…
Attention off-label Covid-19 treatment enthusiasts: "Among patients hospitalized with mild-to-moderate Covid-19, the use of hydroxychloroquine, alone or with azithromycin, did not improve clinical status at 15 days as compared with standard care." https
RT @DrDenaGrayson: 🚨BREAKING: Randomized study shows that #hydroxychloroquine ± azithromycin has NO BENEFIT in patients with mild/moderate…
Among patients hospitalized with mild-to-moderate #Covid19, the use of hydroxychloroquine, alone or with azithromycin, did not improve clinical status at 15 days as compared with standard care. NEJM https://t.co/vTah6DD3Ev
RT @DrDenaGrayson: 🚨BREAKING: Randomized study shows that #hydroxychloroquine ± azithromycin has NO BENEFIT in patients with mild/moderate…
RT @DrDenaGrayson: 🚨BREAKING: Randomized study shows that #hydroxychloroquine ± azithromycin has NO BENEFIT in patients with mild/moderate…
#CCC19 HCQ with or without AZI in Mild-to-Moderate Covid-19 | NEJM https://t.co/VXhuaBUcpV Among patients hospitalized with mild/moderate Covid-19, the use of HCQ , alone or with AZI did not improve clinical status at 15 days compared to standard care @Nic
Hydroxychloroquine +/- Azithromycin in Mild-to-Moderate Covid-19 [Jul 23, 2020] Cavalcanti et al. @NEJM https://t.co/GUM6OwRG6p #COVID19 #COVID19ClinicalTrials #NCT04322123 n=667, w/ 504 #2019nCoV confirmed. Primary outcome was clinical status at 15 days.
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals.
RT @PauloLotufo: Brasil chuta a cloroquina. Parabéns, aos meus seguidores @f_g_zampieri @leticiakawano pela publicação e pelo sigilo mantid…
Resultados do Coalizão, talvez o maior esforço brasileiro para avaliar o uso da hidroxicloroquina no contexto de Covid-19.
RT @matthewherper: NEJM just posted a randomized controlled trial of hydroxychloroquine, hydroxychloroquine and azithromycin, or standard o…
Might interest @MartineWonner @raoult_didier https://t.co/ZjBCcc6ldE
RT @jdflaysakier: L’essai brésilien HCQ+ azithro mentionné plus tôt cet après-midi. Randomisé, formes legères et modérées de #Covid_19 ESS…
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
Another one. Lancetgate happened however I still having seen convincing evidence for hydroxychloroquine
RT @DrDenaGrayson: 🚨BREAKING: Randomized study shows that #hydroxychloroquine ± azithromycin has NO BENEFIT in patients with mild/moderate…
Hydroxychloroquine Doesn't Work https://t.co/F7GD2Pg0wJ https://t.co/v9XE9yvhqV
Infelizmente, não vai mudar nada para os cloroquiners. Vão dizer que não adianta para hospitalizados, mas apenas para quem está no início da infecção.
RT @DrDenaGrayson: 🚨BREAKING: Randomized study shows that #hydroxychloroquine ± azithromycin has NO BENEFIT in patients with mild/moderate…
RT @jdflaysakier: L’essai brésilien HCQ+ azithro mentionné plus tôt cet après-midi. Randomisé, formes legères et modérées de #Covid_19 ESS…
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
Brought to you in part by your very own @f_g_zampieri!
RT @BogochIsaac: No benefit of hydroxychloroquine in a well-designed study: "Among patients hospitalized with mild-to-moderate #COVID19, t…
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
RT @DrDenaGrayson: 🚨BREAKING: Randomized study shows that #hydroxychloroquine ± azithromycin has NO BENEFIT in patients with mild/moderate…
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals. https://t.co/v2CunAcerA
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals. https://t.co/v2CunAcerA
HCQ +/- Azithro no impact mild-moderate #COVID19 @NEJM https://t.co/Ab8vfHJUFY Its almost as if the drug doesn't work.... https://t.co/WAyGMzVR8U
RT @matthewherper: NEJM just posted a randomized controlled trial of hydroxychloroquine, hydroxychloroquine and azithromycin, or standard o…
L’essai brésilien HCQ+ azithro mentionné plus tôt cet après-midi. Randomisé, formes legères et modérées de #Covid_19 ESSAI NEGATIF ( lachez les trolls) https://t.co/aXuWHr2iHU
RT @DrDenaGrayson: 🚨BREAKING: Randomized study shows that #hydroxychloroquine ± azithromycin has NO BENEFIT in patients with mild/moderate…
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
NEJM just posted a randomized controlled trial of hydroxychloroquine, hydroxychloroquine and azithromycin, or standard of care in 55 hospitals in Brazil. No benefit was shown for either HCQ or the HCQ+AZ combo. Big caveat: the study is fairly small. http
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals. https://t.co/v2CunAcerA
#BREAKING hydroxychloroquine #coronavirus
RT @DrDenaGrayson: 🚨BREAKING: Randomized study shows that #hydroxychloroquine ± azithromycin has NO BENEFIT in patients with mild/moderate…
RT @deniswirtz: I have never seen so many negative results published in so many prestigious journals. https://t.co/v2CunAcerA
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
.@raoult_didier a beau clamer haut et fort que « son » hydroxychloroquine et « son » azithromycine sont efficaces, inlassablement toutes les études de qualité reviennent négatives. Celle du soir dans le NEJM: https://t.co/6fAzWpzlr8 Cela en devient ridicul
Study showing #Hydroxychloroquine doesn't work for #covid_19 number 7373874636 I can't wait for the next one https://t.co/J560vezRcn
RT @DrDenaGrayson: 🚨BREAKING: Randomized study shows that #hydroxychloroquine ± azithromycin has NO BENEFIT in patients with mild/moderate…
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
RT @BogochIsaac: No benefit of hydroxychloroquine in a well-designed study: "Among patients hospitalized with mild-to-moderate #COVID19, t…
RT @EricTopol: Another day, another report on hydoxychloroquine absence of efficacy. New @NEJM trial published today https://t.co/k2oCZhtw0…
RT @leticiakawano: 1/ Our study (Coalition I) on HCQ and azithromycin for #Covid19 is out! This study is the effort of an unprecedented co…
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
@Villabelza1 @Julbert86 @ErrajimSheitan @raoult_didier Il n'est pas plus boss q'un autre boss et même les boss peuvent se planter. Je te laisse avec un peu de lecture toute fraîche, qui ravira notre ami commun Didi j'en suis certain : https://t.co/d9y2vny
RT @otavio_ranzani: Estudo randomizado brasileiro no @NEJM testando Hidroxicloroquina e Azitromicina. Parabéns a todas e todos! O result…
RT @EricTopol: Another day, another report on hydoxychloroquine absence of efficacy. New @NEJM trial published today https://t.co/k2oCZhtw0…